Find comprehensive information on Gestational Diabetes Mellitus GDM diagnosis codes ICD10 O244 O249 and clinical documentation improvement CDI best practices. Learn about GDM diagnosis criteria during pregnancy, glucose tolerance testing GTT management, and postpartum care. This resource offers guidance on accurate medical coding for GDM complications, ensuring proper reimbursement and optimal patient care for healthcare professionals. Explore resources for diabetes educators, clinicians, and medical coders seeking information on gestational diabetes.
Also known as
Gestational diabetes mellitus
Diabetes mellitus first diagnosed during pregnancy.
Diabetes mellitus in pregnancy
Diabetes complicating pregnancy, childbirth, and the puerperium.
Diabetes mellitus
Covers various types of diabetes, excluding gestational.
Supervision of high-risk pregnancy
Includes supervision related to gestational diabetes.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diabetes mellitus clearly gestational?
When to use each related code
| Description |
|---|
| Gestational diabetes |
| Pre-existing diabetes in pregnancy |
| Type 2 diabetes mellitus |
Using O24.4XX without specifying type/complication risks inaccurate reimbursement and data analysis. Proper 5th digit needed.
Miscoding pre-existing diabetes (E08-E13) as GDM (O24.4XX) leads to incorrect reporting and skewed quality metrics.
Coding GDM (O24.4XX) without confirmatory diagnostic testing risks overcoding and impacts clinical data integrity.
Q: What are the latest evidence-based diagnostic criteria for Gestational Diabetes Mellitus (GDM) using a 75g oral glucose tolerance test (OGTT)?
A: The current diagnostic criteria for GDM, according to professional organizations like the American Diabetes Association (ADA), using a 75g OGTT are as follows: fasting plasma glucose level >= 92 mg/dL (5.1 mmol/L), 1-hour plasma glucose level >= 180 mg/dL (10.0 mmol/L), and 2-hour plasma glucose level >= 153 mg/dL (8.5 mmol/L). Diagnosis is made if any one of these thresholds is met or exceeded. These criteria are based on data demonstrating adverse perinatal outcomes associated with these glucose levels. Explore how different international guidelines may have slight variations and consider implementing standardized protocols for consistent GDM diagnosis in your practice.
Q: How can I differentiate between physiological insulin resistance in pregnancy and Gestational Diabetes Mellitus (GDM) in clinical practice?
A: While physiological insulin resistance is a normal adaptation during pregnancy to ensure adequate glucose supply to the fetus, GDM represents a pathological state of insulin resistance. Differentiating between the two requires careful evaluation of glucose levels using the 75g OGTT diagnostic criteria. While mild elevations in fasting glucose can be seen in normal pregnancy due to increased placental hormones, exceeding the diagnostic thresholds indicates GDM. Furthermore, evaluating risk factors such as family history of diabetes, obesity, previous history of GDM, and ethnicity can aid in early identification. Learn more about the hormonal changes in pregnancy and their impact on glucose metabolism to better understand this dynamic process.
Patient presents with gestational diabetes mellitus (GDM), diagnosed at [gestational age] weeks based on abnormal glucose tolerance test results. Risk factors for gestational diabetes include family history of type 2 diabetes, advanced maternal age, obesity, previous history of GDM, and ethnicity with high prevalence of diabetes. Initial screening with a 1-hour 50g glucose challenge test revealed a blood glucose level of [value] mg/dL. Subsequent 3-hour 100g oral glucose tolerance test (OGTT) showed elevated glucose levels at [1-hour value] mg/dL, [2-hour value] mg/dL, and [3-hour value] mg/dL, meeting the diagnostic criteria for gestational diabetes. Patient denies polyuria, polydipsia, or polyphagia. Current symptoms include mild fatigue. Physical examination is unremarkable. Assessment includes gestational diabetes, uncontrolled. Plan includes initiation of medical nutrition therapy (MNT) with a focus on carbohydrate control, blood glucose self-monitoring four times daily (fasting and 2 hours postprandial), and patient education on diabetes management during pregnancy. Patient will be followed closely for fetal macrosomia and other potential complications of GDM. Follow-up appointment scheduled in one week to assess response to MNT. If blood glucose targets are not met with diet, insulin therapy will be considered. ICD-10 code O24.41, uncontrolled gestational diabetes.